Top Markets
Coin of the day
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
주식 순위 #28166
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
주가
$0.5495
마지막 동기화: 2025-05-15
시가총액
$28.14M
변동 (1일)
4.70%
변동 (1년)
0.00%
국가
US
거래 Enzo Biochem, Inc. (ENZ)

카테고리

Enzo Biochem, Inc. (ENZ)의 P/E 비율
August 2026 기준 P/E 비율 TTM: -0.62
Enzo Biochem, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/E (TTM) 비율은 -0.62입니다. 2023년 말 기준 P/E 비율은 3.59였습니다.
Enzo Biochem, Inc.의 P/E 비율 기록 (2000 ~ 2026)
매년 말 P/E 비율
연도 P/E 비율 변화
2026 (TTM) -0.62 -72.41%
2024 -2.23 -162.05%
2023 3.59 -168.85%
2022 -5.21 -111.36%
2021 45.87 -1,469.40%
2020 -3.35 78.71%
2019 -1.87 -90.67%
2018 -20.09 -90.00%
2017 -200.84 -3,032.49%
2016 6.85 -111.50%
2015 -59.55 190.81%
2014 -20.48 332.49%
2013 -4.73 219.47%
2012 -1.48 -86.89%
2011 -11.31 43.80%
2010 -7.86 -3.16%
2009 -8.12 -83.50%
2008 -49.20 45.77%
2007 -33.75 27.33%
2006 -26.50 -114.85%
2005 178.44 -370.03%
2004 -66.08 -139.03%
2003 169.30 211.46%
2002 54.36 -45.50%
2001 99.74 -51.07%
2000 203.85 0.00%
유사 기업 또는 경쟁사의 P/E 비율
회사 P/E 비율 P/E 비율 차이 국가
31.59 -5,234.81%
US
35.83 -5,923.48%
US
- -
CN
-227.89 36,937.17%
US
38.69 -6,388.15%
US
P/E 비율 읽는 방법

P/E 비율은 회사의 주가와 주당순이익 간의 관계를 측정합니다.
낮지만 양수인 P/E는 현재 가치 대비 높은 수익을 내고 있는 저평가된 기업을 의미합니다. 높은 음수(0에 가까운) P/E는 큰 손실을 나타냅니다.

P/E가 30을 초과하거나 음수인 기업은 일반적으로 '성장주'로 간주되며, 투자자들은 향후 수익성 개선을 기대합니다.

양의 P/E가 10 미만인 기업은 일반적으로 '가치주'로 간주되며, 이미 매우 수익성이 높고 향후 큰 성장은 기대되지 않습니다.